- In-Patients Multidisciplinary medication review.
K Boukadida
- Insights into class B GPCR activation from structure-function analysis of the adrenomedullin N-terminus
S Hay, M Au, M Brimble, E Burns, M Garelja, J Gingell, A Lovell, D Poyner, N Prodan, C Reynolds, H Watkins, G Williams, P Harris
- In silico and in vitro approaches to develop Dimethylarginine dimethylaminohydrolase-1 inhibitors
C Smith, M Zloh, S Rossiter
- In silico and in vitro approaches to develop Dimethylarginine dimethylaminohydrolase-1 inhibitors
C Smith, M Zloh, S Rossiter
- In Silico Modelling of a Hollow Fibre Bioreactor for Hepatotoxicity Testing
S Webb, I Sorrell, S Regan, J Ward, M Ellis, M Storm, D Williams
- In silico simulation of the impact of genetic polymorphisms on long-acting injectable medicines
R. Abutaima, R. K. Rajoli, A. Owen, M. Siccardi. Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom
- Insulin-like peptide 5 and relaxin-3 inhibit cholinergically-mediated contractions in mouse but not human isolated colon
F Scott, R Shahid, J Broad, MA Kouassi, V Kung, A Palmer, G Sanger
- Insulin Receptor Polymorphisms; Predictors Of Pharmaco-resistance
S Haddad, G Sills
- Insulin sensitivity in vivo is enhanced by systemic administration of S-nitrosothiols but not by SIN-1 in Wistar rats
Guarino MP, Macedo MP
- Insurmountable CCR4 antagonists are less effective at inhibiting CCR4-agonist induced actin polymerisation in regulatory T cells than other T cell phenotypes.
Hall David
